[PDF][PDF] Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19)

B Shanmugaraj, K Siriwattananon… - Asian Pacific journal …, 2020 - apjai-journal.org
Last decade witnessed the outbreak of many life-threatening human pathogens including
Nipah, Ebola, Chikungunya, Zika, Middle East respiratory syndrome coronavirus (MERS …

[HTML][HTML] Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies

MS Maddur, P Miossec, SV Kaveri, J Bayry - The American journal of …, 2012 - Elsevier
Th17 cells that secrete the cytokines IL-17A and IL-17F and express lineage-specific
transcription factor RORC (RORγt in mice) represent a distinct lineage of CD4+ T cells …

S100A8-S100A9 protein complex mediates psoriasis by regulating the expression of complement factor C3

HB Schonthaler, J Guinea-Viniegra, SK Wculek… - Immunity, 2013 - cell.com
Psoriasis is a common heterogeneous inflammatory skin disease with a complex
pathophysiology and limited treatment options. Here we performed proteomic analyses of …

Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis

A Ephrem, S Chamat, C Miquel… - Blood, The Journal …, 2008 - ashpublications.org
The clinical use of intravenous immunoglobulin (IVIg) based on its immunomodulatory and
anti-inflammatory potential remains an ongoing challenge. Fcγ receptor-mediated effects of …

Nanomedicine delivers promising treatments for rheumatoid arthritis

LK Prasad, H O'Mary, Z Cui - Nanomedicine, 2015 - Taylor & Francis
An increased understanding in the pathophysiology of chronic inflammatory diseases, such
as rheumatoid arthritis, reveals that the diseased tissue and the increased presence of …

Intravenous immunoglobulins in immunodeficiencies: more than mere replacement therapy

SV Kaveri, MS Maddur, P Hegde… - Clinical & …, 2011 - Wiley Online Library
Intravenous immunoglobulin (IVIG) is a therapeutic compound prepared from pools of
plasma obtained from several thousand healthy blood donors. For more than 20 years, IVIG …

Advances in the understanding of the mechanism of action of IVIg

HP Hartung - Journal of neurology, 2008 - Springer
The IgG molecule is the main component of IVIg. Commercial preparations of IVIg are
derived from a pool of donors and subsequently, IVIg products contain smaller amounts of …

Structural and thermodynamic insights into antibody light chain tetramer formation through 3D domain swapping

T Sakai, T Mashima, N Kobayashi, H Ogata… - Nature …, 2023 - nature.com
Overexpression of antibody light chains in small plasma cell clones can lead to misfolding
and aggregation. On the other hand, the formation of amyloid fibrils from antibody light …

Intravenous immunoglobulin therapy in rheumatic diseases

J Bayry, VS Negi, SV Kaveri - Nature Reviews Rheumatology, 2011 - nature.com
Prepared from the collective plasma of several thousand people, therapeutic intravenous
immunoglobulin (IVIg) consists mostly of human polyspecific IgG. In addition to its use in …

Efficacy and safety of intravenous and subcutaneous immunoglobulin therapy in idiopathic inflammatory myopathy: A systematic review and meta-analysis

RP Goswami, SN Haldar, M Chatterjee, P Vij… - Autoimmunity …, 2022 - Elsevier
Objective To perform a systematic review and meta-analysis on the efficacy and safety of
intravenous (IVIg) and subcutaneous (SCIg) immunoglobulin (Ig) therapy in the treatment of …